Assignee
FOGHORN THERAPEUTICS INC
US·20 granted patents·34 pending applications·73 citations·filing 2019–2025
Top patents by PatentIndex Score
54 records- 0195US11560381B1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Granted Jan 24, 2023·12 cites·12 claims
- 0295US11497752B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2019·Granted Nov 15, 2022·7 cites·6 claims
- 0395US11414416B1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Aug 16, 2022·16 cites·15 claims
- 0494US11851445B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·9 cites·6 claims
- 0594US11767330B2Citrate salt, pharmaceutical compositions, and methods of making and using the sameFOGHORN THERAPEUTICS INC·Filed 2022·Granted Sep 26, 2023·5 cites·12 claims
- 0694US11485732B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Nov 1, 2022·8 cites·18 claims
- 0792US12383560B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Granted Aug 12, 2025·1 cites·10 claims
- 0892US11787800B2BRD9 degraders and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·3 cites·24 claims
- 0992US11773085B2Methods and compounds for treating disordersFOGHORN THERAPEUTICS INC·Filed 2020·Granted Oct 3, 2023·10 cites·4 claims
- 1086US12139487B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Nov 12, 2024·1 cites·102 claims
- 1180US12441726B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Oct 14, 2025·1 cites·40 claims
- 1279US12486262B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·0 cites·10 claims
- 1375US2026008778A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1474US12351579B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Jul 8, 2025·0 cites·18 claims
- 1572US2024166668A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1671US2025066354A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1771US2024150348A1Brd9 degraders and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1870US2023129003A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1969US2024150328A1Methods and compounds for treating disordersFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2067US2023142883A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2165US2023066136A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2264US2025241931A1Methods of treating a subject having clinically significant signs and symptoms associated with blood cell differentiationFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2364US2025325553A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2462US2024190894A1Citrate salt, pharmaceutical compositions, and methods of making and using the sameFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2562US2025304596A1Pyrazine derivatives and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2661US2025302832A1Pyrazine derivatives and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2761US2025339441A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2860US12528825B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Jan 20, 2026·0 cites·18 claims
- 2959US12552775B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Feb 17, 2026·0 cites·29 claims
- 3057US2024376121A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3156US2025085300A1Stability-enhancing compositions and methods of preparing compoundsFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3255US2023149414A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3354US12509453B2BRM/BRG1 inhibitors and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Dec 30, 2025·0 cites·19 claims
- 3454US2024374605A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3554US2024024488A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3654US2023416248A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3753US2023121497A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3853US2024325370A1Therapeutic regimens of a degrader of brd9FOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3953US2023348452A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4051US2025255857A1Methods of treating androgen receptor-independent prostate cancerFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4151US2024189318A1Therapeutic regimens of an inhibitor of the enzymatic activity of brg1 and brmFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4251US2023150974A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4350US12590079B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Mar 31, 2026·0 cites·20 claims
- 4450US2025235432A1Methods of treating cancersFOGHORN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4550US2023079819A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4649US2022193205A1Methods of treating cancerFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4748US12391686B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Aug 19, 2025·0 cites·22 claims
- 4848US12384776B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Aug 12, 2025·0 cites·17 claims
- 4948US2023065463A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5044US2021260171A1Methods of treating disordersFOGHORN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →